"discontinuation by" is a grammatically correct phrase and can be used in written English.
It means to stop or end something as a result of someone or something else. It can also imply that the action of discontinuing is being carried out by a specific person or entity. Example: The project was facing discontinuation by the company's new management, causing confusion and delays for the team. In this sentence, "discontinuation by" indicates that the company's new management is responsible for stopping the project, and the result is confusion and delays for the team.
Past research has mainly identified causes for discontinuation by asking patients to state their reasons for discontinuing (hereafter 'stated reasons').
Adverse effects and moderated efficacy of drugs promote treatment discontinuation by patients.
Discontinuation by Design Anwyl says the problems can be traced back to the 1980s, when Oldsmobiles, Buicks, Cadillacs and some Chevrolets all looked alike.
Discontinuation by Design Anwyl says the problems with the brands on their deathbeds can be traced back to the 1980s, when Oldsmobiles, Buicks, Cadillacs and some Chevrolets all looked very much alike.
Kaplan Meier survival analysis estimated the time to treatment discontinuation by the treatment group, Cox proportional hazards regression models identified the variables associated with treatment discontinuation (adjusted for baseline differences between treatment groups), and logistic regression models compared the tolerability profiles of the different treatment groups.
In addition, 2 (5.7%) participants in the VivaGel® arm and 4 (21.0%) in the placebo arm did not take all 28 doses due to product discontinuation by study staff; 3 due to early closure of the study, and 3 due to protocol deviations by study staff (Table 2).
Prior anti-TNF therapy was summarised using descriptive statistics by reason for discontinuation and by duration of prior TNF inhibitor for patients who had taken only one prior TNF inhibitor.
Absence of full correspondence between GP-reported treatments and dispensation records in the prescription database may be explained by non-adherence, discontinuation elected by the patient, or use of extra-regional or hospital-based pharmacies.
Given that our exposure and reference groups differed by discontinuation rather than by initiation of supplementation, it seems unlikely that the two groups would differ by key determinants of survival.
Patients who discontinued prematurely completed final visit (month 12) assessments at the time of discontinuation, followed by the 4-week follow-up.
Menstrual and medical disturbances were the principal reasons for discontinuation, followed by planned pregnancy.
